switching from compounded tirzepatide to zepbound Semaglutide Tirzepatide: Is It a Good Idea? Compounded Tirzepatide vs Mounjaro/Zepbound: 75%

Tirzepatide is a dual GIP and GLP-1 receptor agonist

Digestive changes including altered bowel movement frequency or consistency typically start within the first week

Mounjaro is FDA-approved for type 2 diabetes in adults, while Zepbound is approved for chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related condition and for treatment of moderate to severe obstructive sleep apnea in obese adults

Company Ozempic, Wegovy, and Rybelsus are Manufactured by Novo Nordisk A/S, DK-2880 Bagsvaerd, Denmark

It should not be used with other GLP-1 receptor agonist medicines